CHINA ORAL IND: Actively promoting the deep application of artificial intelligence computing resources in core medical and oral businesses, and developing related digital infrastructure

According to the announcement from CHINA ORAL IND (08406), in order to align with the global development trend of digital medical technology and promote the long-term growth of the group, the group is actively promoting the deep application of artificial intelligence (AI) computing resources in core medical and oral businesses, and developing related digital infrastructure. The group aims to become an industry partner and strategic investor, participating in the construction of medical AI computing networks and data infrastructure, supporting various scenarios including medical imaging diagnosis, clinical decision support, and intelligent medical services.

The key areas of focus for related AI medical applications are as follows: establishing a large-scale medical AI computing network, which can significantly enhance the automated intelligent analysis capabilities in fields such as medical imaging (e.g., X-ray imaging, computed tomography (CT), magnetic resonance imaging (MRI)), pathological diagnosis, and genetic analysis, assisting doctors in making faster and more accurate clinical decisions. Creating a medical data security circulation and management platform to promote compliant sharing of medical data resources, effectively facilitating innovative applications such as new drug development, disease prediction, and telemedicine. Introducing internationally advanced medical AI technologies and resources from cross-disciplinary professional institutions to strengthen the group's advantages in medical services and technological empowerment, improving service quality and operational efficiency.

This strategic deployment is of great significance to the group. By integrating the existing medical and oral industry foundation of the group and deepening the application of artificial intelligence computing resources, it will significantly enhance service quality and operational efficiency, allowing the group to closely follow the development trend of the digital medical industry and proactively seize market opportunities brought by technological changes. Through continuous strengthening of technological capabilities and digital infrastructure, the group expects to expand its service scope, attract more high-quality medical institutions and strategic partners, further consolidate its industry position, and potentially explore new growth points. Ultimately, this will promote the sustainable development of the group and create long-term and stable value returns for shareholders